VNRX logo

VNRX VolitionRX Ltd

New York Stock Exchange Arca · Medical - Devices · Healthcare

$0.16
-0.02 (-10.00%)

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleoso…

Market Cap: $1.98Mvolition.com

Price

No data yet.

Social Signal Score

43
5d
—
30d
43
6 mentions
—
60d
43
6 mentions
—
90d
43
12 mentions
—
news: 12

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 3Sell 0Strong Sell 0

Revenue

$1.61M
$0.00$538.0K$1.08M$1.61M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-3.34
$-3.98–$-2.69
3 analysts
FY2026
$-1.60
$-2.55–$-1.03
1 analysts
FY2027
$-0.41
$-0.65–$-0.26
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Cameron Reynolds
Sector
Healthcare
Industry
Medical - Devices
Employees
57
Beta
1.16
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-60.99
volition.com